Ankur Capital, a Technology-focused venture capital company, has secured Rs 330 crore ahead of an interim close of second fund.
Its co-founders informed, “The total target size of the fund is around Rs 350 crore, with an option to retain another Rs 50 crore depending on investor interest.”
Co-founder – Ritu Verma, added, “We have received commitments worth Rs 330 crore from our existing as well as new investors.”
Investors who have backed the new fund are Dutch Good Growth Fund, Small Industries Development Bank of India, CDC Group, MacArthur Foundation, BIRAC and Nabard.
“BIRAC is pleased to partner with Ankur Capital under its Fund of Funds scheme – AcE – to support biotech innovations. We look forward to venture funds like AcE Fund Partner – Ankur Capital and encourage private equity mobilisation into the biotech innovation ecosystem. This will benefit the rapidly expanding pipeline of biotech startups who develop technology led innovative products to address unmet needs for India and the world,” Head – Strategy Partnership & Entrepreneurship Development, BIRAC – Manish Diwan, said.
Arya has been a part of the Content & Research Team at Hrnxt.com. She is a keen observer of economic developments, emerging businesses, people in business and keeps a tab on latest happenings in the business environment.